Connecting Research and Experts with Journalists

• share
• favorite_border

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University.

• share
• favorite_border

Hubble witnessed a dwarf galaxy crashing through the Milky Way galaxy's gaseous halo and living to tell the tale...though a bit worse for wear!

• share
• favorite_border

Researchers from the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children’s Hospital analyzed six years of multistate child death review data from the United States and found that 81% of sexual and gender diverse youth in the dataset died by suicide, despite many receiving current or prior mental health services.

• share
• favorite_border

Electronics and Telecommunications Research Institute (ETRI) announced that they have developed a system capable of controlling eight photons using a photonic integrated-circuit chip. With this system, they can explore various quantum phenomena, such as multipartite entanglement resulting from the interaction of the photons.

• share
• favorite_border

If you want to seem sincere and receive more responses to your texts, spell out words instead of abbreviating them, according to new research published by the American Psychological Association.

• share
• favorite_border

Researchers have identified new roles for a protein long known to protect against severe flu infection – among them, raising the minimum number of viral particles needed to cause sickness.

• share
• favorite_border

KRICT sets a new world record for large-area perovskite solar module efficiency and accelerates commercialization

• share
• favorite_border

Community partnerships led to a specialized clinic delivering COVID and flu shots to individuals with neurodevelopmental conditions like autism at the MIND Institute.

• share
• favorite_border

In a groundbreaking study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases—two rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells in the brain and spinal cord. After years of investigating the diseases’ underlying mechanisms, the research team has identified an existing FDA-approved drug that could significantly improve quality of life for affected patients and their families.